Obesity - HealthQuill

Novo Nordisk has inked a $2 billion licensing pact with United Laboratories International for the development, manufacturing and commercialising of the Chinese company’s “triple G” weight-loss candidate.

Novo Nordisk in $2b deal with Chinese firm for ‘triple-G’ obesity drug

HQ Team February 25, 2025: Novo Nordisk has inked a $2 billion licensing pact with United Laboratories International for the development, manufacturing and.

by HealthQuill
March 25, 2025
0 Comments

Obesity is a health risk that needs to be tackled worldwide

Health Medical

Weight loss offers health benefits, even if pounds creep back: Study

Bharti Jayshankar March 24, 2025: University of Gothenburg researchers have uncovered a silver lining for those who struggle to maintain weight loss. According.

by HealthQuill
March 24, 2025
0 Comments

AbbVie Inc. will license a drug to treat obesity from Denmark’s Gurba A/S, a preclinical contract research services and peptide-based drug discovery, for about $2.2 billion to mark its entry into the obesity treatment space.

Drugs Medical Pharma

AbbVie inks $2.2b deal with Denmark’s Gurba, enters weight-loss market

HQ Team March 4, 2025: AbbVie Inc. will license a drug to treat obesity from Denmark’s Gurba A/S, a preclinical contract research services.

by HealthQuill
March 4, 2025
0 Comments

Drugs Health Pharma

Eli Lilly cuts price of weight-loss drug Zepbound to take on copycats

Eli Lilly and Company cut the prices of its weight-loss drug Zepbound, available in single-dose vials, in a bid to end compounding companies from.

by HealthQuill
February 25, 2025
0 Comments

Scientists have created an atlas of individual cells within the human brain region of the hypothalamus and identified new genes linked to obesity that may lead to novel therapies.

Uncategorized

New obesity, diabetic cures may emerge as scientists unveil brain atlas

Scientists have created an atlas of individual cells within the human brain region of the hypothalamus and identified new genes linked to obesity.

by HealthQuill
February 7, 2025
0 Comments

Obesity, as defined by the standard body mass index, is erroneous, and the condition should be split into two — pre-clinical and clinical, according to an international commission.

Health Pharma Research

Beyond body mass index, experts hone in on new definition of obesity

Obesity, as defined by the standard body mass index, is erroneous, and the condition should be split into two — pre-clinical and clinical,.

by HealthQuill
January 16, 2025
0 Comments

Novo Nordisk A/S, a Danish pharmaceutical company, has expanded its agreement with US-based Valo Health Inc., almost to double the number of drugs to be jointly developed, according to a statement.

Drugs Health Medical

Novo Nordisk, Valo expand pact to include obesity, diabetic drugs

Novo Nordisk A/S, a Danish pharmaceutical company, has expanded its agreement with US-based Valo Health Inc., almost to double the number of drugs.

by HealthQuill
January 9, 2025
0 Comments

Eli Lilly and Company will invest $3 billion in the US to expand its manufacturing facility to meet a rise in demand for medicines in the areas of diabetes and obesity.

Uncategorized

Eli Lilly to expand US facility as demand soars for diabetes, obesity medicines

Eli Lilly and Company will invest $3 billion in the US to expand its manufacturing facility to meet a rise in demand for.

by HealthQuill
December 9, 2024
0 Comments

Health

Lilly’s trial results for treating obesity and pre-diabetes are promising

HQ Team November 15, 2024: Eli Lilly’s Phase III trial has yielded positive results from the SURMOUNT-1 study of tirzepatide (Zepbound and Mounjaro) for.